Verastem | VSTM - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
AbbVie USD 3.59B 28.65B 2025-12
Alaunos Therapeutics USD 613K 230K 2025-12
AstraZeneca USD 22.51B 2.78B 2026-03
Curis USD 5.61M 1.52M 2025-12
Cytokinetics USD 24.71M 80.91M 2026-03
Gilead Sciences USD 645M 70M 2026-03
Incyte USD 228.62M 1.41B 2026-03
Laboratory Of America USD 695.7M 145.1M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
TG Therapeutics USD 148.84M 41.34M 2026-03
Verastem USD 12.45M 2.56M 2025-12